These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 30105918)

  • 1. Sodium stibogluconate loaded nano-deformable liposomes for topical treatment of leishmaniasis: macrophage as a target cell.
    Dar MJ; Din FU; Khan GM
    Drug Deliv; 2018 Nov; 25(1):1595-1606. PubMed ID: 30105918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nano-elastic liposomes as multidrug carrier of sodium stibogluconate and ketoconazole: A potential new approach for the topical treatment of cutaneous Leishmaniasis.
    Dar MJ; Khalid S; Varikuti S; Satoskar AR; Khan GM
    Eur J Pharm Sci; 2020 Mar; 145():105256. PubMed ID: 32032778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and evaluation of novel miltefosine-polyphenol co-loaded second generation nano-transfersomes for the topical treatment of cutaneous leishmaniasis.
    Dar MJ; McElroy CA; Khan MI; Satoskar AR; Khan GM
    Expert Opin Drug Deliv; 2020 Jan; 17(1):97-110. PubMed ID: 31786952
    [No Abstract]   [Full Text] [Related]  

  • 4. Cationic liposomal sodium stibogluconate (SSG), a potent therapeutic tool for treatment of infection by SSG-sensitive and -resistant Leishmania donovani.
    Sinha R; Roychoudhury J; Palit P; Ali N
    Antimicrob Agents Chemother; 2015 Jan; 59(1):344-55. PubMed ID: 25367907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cured immune phenotype achieved by treatment of visceral leishmaniasis in the BALB/c mouse with a nonionic surfactant vesicular formulation of sodium stibogluconate does not protect against reinfection.
    Carter KC; Baillie AJ; Mullen AB
    Clin Diagn Lab Immunol; 1999 Jan; 6(1):61-5. PubMed ID: 9874665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional sodium stibogluconate alone or its combination with either intramuscular sodium stibogluconate or oral ketoconazole in the treatment of localized cutaneous leishmaniasis: a comparative study.
    El-Sayed M; Anwar AE
    J Eur Acad Dermatol Venereol; 2010 Mar; 24(3):335-40. PubMed ID: 19744259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with sodium stibogluconate in stearylamine-bearing liposomes confers cure against SSG-resistant Leishmania donovani in BALB/c mice.
    Roychoudhury J; Sinha R; Ali N
    PLoS One; 2011 Mar; 6(3):e17376. PubMed ID: 21423750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes.
    Dar MJ; Khalid S; McElroy CA; Satoskar AR; Khan GM
    Int J Pharm; 2020 Jan; 573():118900. PubMed ID: 31765786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage targeting with the novel carbopol-based miltefosine-loaded transfersomal gel for the treatment of cutaneous leishmaniasis:
    Batool S; Zahid F; Ud-Din F; Naz SS; Dar MJ; Khan MW; Zeb A; Khan GM
    Drug Dev Ind Pharm; 2021 Mar; 47(3):440-453. PubMed ID: 33615936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitazoxanide and quercetin co-loaded nanotransfersomal gel for topical treatment of cutaneous leishmaniasis with macrophage targeting and enhanced anti-leishmanial effect.
    Bashir S; Shabbir K; Din FU; Khan SU; Ali Z; Khan BA; Kim DW; Khan GM
    Heliyon; 2023 Nov; 9(11):e21939. PubMed ID: 38027656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
    Bavarsad N; Fazly Bazzaz BS; Khamesipour A; Jaafari MR
    Acta Trop; 2012 Oct; 124(1):33-41. PubMed ID: 22750480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacies of vesicular and free sodium stibogluconate formulations against clinical isolates of Leishmania donovani.
    Carter KC; Mullen AB; Sundar S; Kenney RT
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3555-9. PubMed ID: 11709339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of short-duration (twice weekly) intralesional sodium stibogluconate in treatment of cutaneous Leishmaniasis in India.
    Bumb RA; Mehta RD; Ghiya BC; Jakhar R; Prasad N; Soni P; Lezama-Davila C; Satoskar AR
    Br J Dermatol; 2010 Oct; 163(4):854-8. PubMed ID: 20500797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses of Leishmania donovani infected BALB/c mice following treatment with free and vesicular sodium stibogluconate formulations.
    Banduwardene R; Mullen AB; Carter KC
    Int J Immunopharmacol; 1997 Apr; 19(4):195-203. PubMed ID: 9373770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antileishmanial Agents Co-loaded in Transfersomes with Enhanced Macrophage Uptake and Reduced Toxicity.
    Zahid F; Batool S; Ud-Din F; Ali Z; Nabi M; Khan S; Salman O; Khan GM
    AAPS PharmSciTech; 2022 Aug; 23(6):226. PubMed ID: 35970966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fractional ablative carbon dioxide laser followed by topical sodium stibogluconate application: A treatment option for pediatric cutaneous leishmaniasis.
    Hilerowicz Y; Koren A; Mashiah J; Katz O; Sprecher E; Artzi O
    Pediatr Dermatol; 2018 May; 35(3):366-369. PubMed ID: 29574997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical delivery of tetrahydrocurcumin lipid nanoparticles effectively inhibits skin inflammation: in vitro and in vivo study.
    Kakkar V; Kaur IP; Kaur AP; Saini K; Singh KK
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1701-1712. PubMed ID: 29938544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visceral leishmaniasis in the BALB/c mouse: a comparison of the efficacy of a nonionic surfactant formulation of sodium stibogluconate with those of three proprietary formulations of amphotericin B.
    Mullen AB; Baillie AJ; Carter KC
    Antimicrob Agents Chemother; 1998 Oct; 42(10):2722-5. PubMed ID: 9756784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis.
    Solomon M; Baum S; Barzilai A; Scope A; Trau H; Schwartz E
    J Am Acad Dermatol; 2007 Apr; 56(4):612-6. PubMed ID: 17276541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of encapsulated meglumine antimoniate in stearylamine-bearing liposomes against cutaneous leishmaniasis in BALB/c mice.
    Moosavian SA; Fallah M; Jaafari MR
    Exp Parasitol; 2019 May; 200():30-35. PubMed ID: 30898544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.